Acute renal failure in the 21st century: recommendations for management and outcomes assessment

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
T D DuBoseG E Striker

Abstract

Acute renal failure (ARF) remains a common and potentially devastating disorder affecting as many of 5% of all hospitalized patients, with a higher prevalence in patients in critical care units. ARF is more frequently observed in the setting of multiorgan dysfunction syndrome (MODS) and in elderly patients with complex disease, where mortality is high. Numerous technical advances have not yet impacted favorably on this high mortality rate. This report summarizes recommendations from participants at the National Institutes of Health Conference: "Acute Renal Failure in the 21st Century," May 6 to 8, 1996, in Bethesda, MD. The focus is on categorizing recent clinically relevant developments in the field and on identification of new research initiatives to transfer a new body of knowledge derived from fundamental studies and laboratory investigation to the management of ARF in the new millennium. The development of a multicenter database through cooperative multicenter studies is advocated. Future studies should define the appropriate outcome measures to assess and emphasize the impact of hemodynamic monitoring, adjunctive agents, and adequacy and modality of renal replacement therapy on outcomes in ARF.

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jun 1, 1985·Kidney International·S M Moran, B D Myers
Nov 1, 1984·Archives internationales de physiologie et de biochimie·D el AllafJ Carlier
Oct 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J D Conger
Oct 19, 1995·The New England Journal of Medicine·L GattinoniR Fumagalli
Nov 17, 1994·The New England Journal of Medicine·R M HakimR A Parker
Jul 1, 1994·Journal of the American Society of Nephrology : JASN·M R Hammerman, S B Miller
May 30, 1996·The New England Journal of Medicine·R ThadhaniJ V Bonventre
Feb 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·H NeveuP Landais

❮ Previous
Next ❯

Citations

Dec 10, 2003·Expert Opinion on Emerging Drugs·Prabal K Chatterjee, Christoph Thiemermann
Jan 14, 2004·Seminars in Dialysis·Valerie A Luyckx, Joseph V Bonventre
Oct 6, 2005·Intensive Care Medicine·Damien du CheyronPierre Charbonneau
Oct 7, 2005·Journal of the American Society of Nephrology : JASN·David G Warnock
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Zaccaria RicciClaudio Ronco
Jan 18, 2008·Journal of the American Society of Nephrology : JASN·Heng LinRuey-Bing Yang
Apr 25, 2014·Journal of Cellular and Molecular Medicine·Liping LiTongyu Zhu
Mar 5, 1998·The New England Journal of Medicine·S Klahr, S B Miller
Apr 27, 2002·Heart Disease·F H Epstein
May 22, 2003·The International Journal of Artificial Organs·P Passadakis, D Oreopoulos
May 20, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sven R VercauterenMarc E De Broe
Feb 17, 2005·American Journal of Physiology. Renal Physiology·Florian TögelChristof Westenfelder
Dec 2, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David G Warnock
Aug 17, 2012·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Brian D ShelmadineRodney G Bowden
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·P Murray, J Hall
Dec 14, 2004·Journal of Palliative Medicine·Richard SwartzJamie Daley
Feb 24, 2006·American Journal of Physiology. Renal Physiology·Midhun C KorrapatiHarihara M Mehendale
Dec 31, 2004·American Journal of Physiology. Renal Physiology·Dirk M HentschelJoseph V Bonventre
Nov 7, 2001·The Journal of Clinical Investigation·K J KellyP C Dagher
Dec 25, 2009·Renal Failure·Maria O N AvilaEmmanuel A Burdmann
Apr 26, 2011·Scottish Medical Journal·Merlin McMillan, Robert Mactier
Aug 21, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Bruce A Molitoris
Aug 9, 2006·Nature Clinical Practice. Oncology·Elvira RampelloMariano Malaguarnera
Aug 28, 2002·The Annals of Pharmacotherapy·Maria C Pruchnicki, Joseph F Dasta
Dec 16, 1998·Kidney International·R A Star
Apr 19, 2002·Journal of the American Society of Nephrology : JASN·Ravindra L MehtaGlenn M Chertow
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Ravindra L Mehta, Glenn M Chertow
May 21, 1999·The American Journal of Medicine·B A Molitoris, J Marrs
Dec 1, 2001·Journal of the American Society of Nephrology : JASN·Ming YinRonald G Thurman
Sep 5, 2001·Kidney International·R L MehtaUNKNOWN Collaborative Group for Treatment of ARF in the ICU
Jan 5, 2000·Kidney International·C G AckerJ P Johnson
Oct 6, 2004·Best Practice & Research. Clinical Anaesthesiology·Per-Olof Jarnberg
Nov 30, 2000·Anesthesiology Clinics of North America·B C Weldon, T G Monk
Jan 4, 1998·Kidney International·T M Coffman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.